Cochrane corner: beta-blockers for hypertension

Heart

Volumn 104, Issue 4, 2018, Pages 282-283

  Wiysonge, Charles S ^a   Bradley, Hazel A ^b   Volmink, Jimmy ^c   Mayosi, Bongani M ^d,e  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

HUMAN; HYPERTENSION;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION;

EID: 85050389766     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2017-311585     Document Type: Editorial

References (7)

1. Wiysonge CS, Volmink J, Opie LH. Beta-blockers and the treatment of hypertension: it is time to move on. Cardiovasc J Afr 2007;18:351–2.
2. Pucci G, Ranalli MG, Battista F, et al. Effects of β-blockers with and without vasodilating properties on central blood pressure: systematic review and meta-analysis of randomized trials in hypertension. Hypertension 2016;67:316–24.
3. Smithwick RH. An evaluation of the surgical treatment of hypertension. Bull N Y Acad Med 1949;25:698–716.
4. Wiysonge CS, Bradley HA, Volmink J, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev 2017;1:CD002003.
5. Bradley HA, Wiysonge CS, Volmink JA, et al. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens 2006;24:2131–41.
6. Wiysonge CS, Bradley H, Mayosi BM, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev 2007:CD002003.
7. Wiysonge CS, Bradley HA, Volmink J, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev 2012.